Xylem reports higher Q2 earnings and raises 2026 EPS guidance

Xylem reported second-quarter 2026 revenue of $2.3 billion for the period ended June 30, up 2% year over year, while reported EPS rose 19% to $1.11 and adjusted EPS increased 16% to $1.46; orders rose 42% to $3.1 billion. On July 28, 2026, the company raised its full-year adjusted EPS outlook to $5.55-$5.70 from $5.35-$5.60, while lowering its reported revenue outlook to approximately $9.2 billion from its prior 2%-3% growth range.